Hysterectomy rates can be expected to rise slowly in the months and years following endometrial ablation, regardless of ablation device type, a meta-analysis found. Risk of hysterectomy rose to from 4 ...

Tanya Perry was looking for relief from heavy bleeding during her period when her ob/gyn suggested endometrial ablation with the NovaSure device in May 2017. Her doctor told her it would be a quick ...

Please provide your email address to receive an email when new articles are posted on . Live birth rates were similar for women with uterine fibroids who underwent radiofrequency ablation or ...

Please provide your email address to receive an email when new articles are posted on . Reintervention rates were higher for hysteroscopic myomectomy, uterine artery embolization and endometrial ...

Transcervical radiofrequency ablation is a potential minimally invasive alternative for the treatment of symptomatic uterine leiomyomas, also known as fibroids, new research suggests. In the 22-site ...

Over the last 20 years, the NovaSure system has built a trusted legacy in GEA. The NovaSure device first received FDA approval in 2001, and by 2018 the NovaSure procedure had been used to treat over 3 ...

“Since its launch over 20 years ago, we have constantly listened to our customers’ feedback, which has driven continuous design improvements for NovaSure,” said Jan Verstreken, Group President, ...

AUSTIN, Texas--(BUSINESS WIRE)--Acessa Health Inc., developer of the Acessa Procedure™, announced today the successful launch and U.S. commercial availability of the Acessa ProVu System. Acessa ProVu ...

About 11 million women in the U.S. are currently diagnosed with uterine fibroids, while 3.7 million undiagnosed women report having symptoms suggestive of uterine fibroids, according to medical tech ...

CMS has approved ASCs as a site of service for transcervical uterine fibroid ablation — a minimally invasive procedure for symptomatic uterine fibroids that can be performed with the Sonata System ...